摘要
应用流式细胞仪(FCM)对62例临床常规胃镜活检组织进行检测,建立了常规胃锐活检组织的FCM检测诊断标准,分为FCM检测阳性(+)、可疑(±)及正常(-)三级。慢性萎缩性胃炎及异型增生组中FCM阳性率为22%(4/18),可疑为33%(6/18).胃癌组中FCM阳性检出率为70%(14/20),24例基本正常胃粘膜(包括浅表性胃炎)组均为二倍体DNA。我们认为,FCM可疑及阳性可能为重要的癌变标志,FCM检测可用于胃癌前病变的动态观察。
Sixty-two samples from human gastric endoscopic biopsies were analysed in order to detect DNA ploidy content alterations as markers for cancerous and precancerous lesions of the stomach.The criterion for diagnosis by FCM consisted of FCM positive(+).suspicious(±)and negative(-).All the samples of normal mucosa(including superficial gastritis)showed a diploid DNA content.In the group of chronic atrophic gastritis and gastric dysplasia,positive rate was 22%(4/18) and suspicious rate was 33%(6/18).Whereas FCM positive rate was 70%in 20 patients with gastric cancer. It is likely that FCM positive and suspicious may be one of the important markers for cancerous and precancerous diagnosis.
出处
《肿瘤》
CAS
CSCD
北大核心
1994年第3期145-148,共4页
Tumor
基金
国家自然科学基金
关键词
流式细胞仪
胃肿瘤
萎缩性胃炎
Gastric endoscopic biopsies Stomach neoplasms Chronic atrophic gastritis Dysplasia Flow cytometry